Cargando…

High-dose budesonide for early COVID-19

Detalles Bibliográficos
Autores principales:	Lipworth, Brian, Chan, Rory, Misirovs, Rasads
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660033/ https://www.ncbi.nlm.nih.gov/pubmed/34895529 http://dx.doi.org/10.1016/S0140-6736(21)02440-5

Ejemplares similares

Phenotypic associations of medical polypectomy and revision surgery following endoscopic sinus surgery: a retrospective study of a single-centre experience in Scotland
por: Misirovs, Rasads, et al.
Publicado: (2023)

High-dose budesonide for early COVID-19
por: Berezowski, Ivan, et al.
Publicado: (2021)

High-dose budesonide for early COVID-19 – Authors' reply
por: Hobbs, F D Richard, et al.
Publicado: (2021)

Inhaled budesonide for early treatment of COVID-19
por: Choi, Jae Chol, et al.
Publicado: (2021)

Inhaled budesonide for early treatment of COVID-19
por: San-Juan, Rafael, et al.
Publicado: (2021)

Inhaled budesonide for early treatment of COVID-19
por: Zeitlinger, Markus, et al.
Publicado: (2021)

Inhaled Corticosteroids and COVID-19
por: Lipworth, Brian, et al.
Publicado: (2020)

COVID-19: Start with the nose
por: Lipworth, Brian, et al.
Publicado: (2020)

Inhaled budesonide for early treatment of COVID-19 – Authors' reply
por: Ramakrishnan, Sanjay, et al.
Publicado: (2021)

Tocilizumab for severe COVID-19 pneumonia
por: Lipworth, Brian J, et al.
Publicado: (2020)

Disconnect for Tezepelumab on Exacerbations, Symptoms, and Quality of Life in Type 2 Low Asthma
por: Lipworth, Brian, et al.
Publicado: (2023)

Inhaled corticosteroids and angiotensin-converting enzyme-2 in COPD
por: Lipworth, Brian, et al.
Publicado: (2021)

Systemic IL-6 and Severe Asthma
por: Lipworth, Brian, et al.
Publicado: (2020)

Sex Hormones and Asthma: Don’t Forget Progesterone
por: Lipworth, Brian, et al.
Publicado: (2020)

Don’t Forget about Facilitatory Effects of Corticosteroids on β(2)-Adrenoceptors in Acute Asthma
por: Lipworth, Brian, et al.
Publicado: (2020)

Budesonide/formoterol combination for reducing cough in COVID-19 patients—A case of inflated expectations!
por: Kaur, Onkardeep, et al.
Publicado: (2023)

Benefit:Risk Profile of Budesonide in Obstructive Airways Disease
por: Tashkin, Donald P., et al.
Publicado: (2019)

Predicting Severe Outcomes in COVID-19
por: Lipworth, Brian, et al.
Publicado: (2020)

Corticosteroid Protection Against COVID-19: Begin with the Nose
por: Lipworth, Brian J., et al.
Publicado: (2021)

Budesonide: A promising candidate therapeutic for early COVID-19
por: Patel, Shailesh Kumar, et al.
Publicado: (2021)

High-Dose Prophylactic Anticoagulation in Severe COVID-19 Pneumonia
por: Nadeem, Rashid, et al.
Publicado: (2021)

Type 2 Asthma Inflammation and COVID-19: A Double Edged Sword
por: Lipworth, Brian, et al.
Publicado: (2021)

COVID-19 in the Critically Ill: Too Risky for High-Dose Anticoagulation?
por: Paez Vargas, Juan José, et al.
Publicado: (2021)

Resistance Heterogeneity and Small Airway Asthma Phenotype
por: Lipworth, Brian, et al.
Publicado: (2019)

Early treatment with inhaled budesonide to prevent clinical deterioration in patients with COVID-19
por: Agusti, Alvar, et al.
Publicado: (2021)

Is inhaled budesonide an effective treatment for patients with mild early symptoms of COVID-19?
por: Kareemi, Hashim, et al.
Publicado: (2021)

Standard Dose Ivermectin for COVID-19
por: Buonfrate, Dora, et al.
Publicado: (2021)

High Uptake of Three COVID-19 Vaccine Doses Among Liver Transplant Recipients
por: Schell, Trevor L., et al.
Publicado: (2023)

Safety and efficacy of the Russian COVID-19 vaccine: more information needed
por: Bucci, Enrico, et al.
Publicado: (2020)

VITT and Second Doses of Covid-19 Vaccine
por: Lacy, Joanne, et al.
Publicado: (2021)

Efficacy of budesonide/formoterol maintenance and reliever therapy compared with higher-dose budesonide as step-up from low-dose inhaled corticosteroid treatment
por: Jenkins, Christine R., et al.
Publicado: (2017)

Oral dexamethasone for COVID-19 patients at the initial recognition of hypoxia: Can an early dose herald a better outcome?
por: Lo, Ching-Lung, et al.
Publicado: (2022)

Normal spirometry equates to normal impulse oscillometry in healthy subjects
por: Lipworth, Brian, et al.
Publicado: (2021)

Forced Vital Capacity and Low Frequency Reactance Area Measurements Are Associated with Asthma Control and Exacerbations
por: Chan, Rory, et al.
Publicado: (2022)

Medium-term repeatability for airwave oscillometry in patients with severe asthma taking benralizumab
por: Chan, Rory, et al.
Publicado: (2023)

Inhalatives Budesonid zur Therapie bei COVID-19
por: Kluge, S., et al.
Publicado: (2021)

Tocilizumab in COVID-19: finding the optimal route and dose
por: Jain, Siddharth, et al.
Publicado: (2020)

Anti-FXa Activity with Intermediate-Dose Thromboprophylaxis in COVID-19
por: Rappaport, Stephen H., et al.
Publicado: (2020)

COVID-19 booster doses in pregnancy and global vaccine equity
por: Kalafat, Erkan, et al.
Publicado: (2022)

Hydroxychloroquine for prophylaxis in COVID-19: Need to revisit dosing regimen
por: Pareek, Anil, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_q291dd52tovgv82qgtg80u6gqd